T1	Participants 83 130	children receiving combined cancer chemotherapy
T2	Participants 281 330	adults and children receiving cancer chemotherapy
T3	Participants 466 540	children receiving highly emetogenic chemotherapy for various malignancies
T4	Participants 542 606	A total of 51 children (mean age: 7.7 +/- 4.8 year) were studied
